Rabbit Recombinant Monoclonal BMP7 antibody. Suitable for IP, WB and reacts with Human, Mouse, Rat, Recombinant fragment - Human samples. Cited in 12 publications.
View Alternative Names
OP1, BMP7, Bone morphogenetic protein 7, BMP-7, Osteogenic protein 1, OP-1
- IP
Lab
Immunoprecipitation - Anti-BMP7 antibody [EPR5897] (AB129156)
Purified ab129156 at 1/150 immunoprecipitating BMP7 in MCF7 (Human breast adenocarcinoma cell line) whole cell lysate observed at 49 KDa (lanes 1 and 2).
Lane 1 (input) : MCF7 whole cell lysate 10μg
Lane 2 (+) : ab129156 + MCF7 whole cell lysate.
Lane 3 (-) : Rabbit monoclonal IgG (ab172730) instead of ab129156 in MCF7 whole cell lysate
For western blotting, ab129156 at 1/150 dilution and VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/1000 dilution.
Blocking and Diluting buffer and concentration : 5% NFDM/TBST.
All lanes:
Immunoprecipitation - Anti-BMP7 antibody [EPR5897] (ab129156)
Predicted band size: 49 kDa
false
- WB
Unknown
Western blot - Anti-BMP7 antibody [EPR5897] (AB129156)
Blocking/Diluting buffer 5% NFDM/TBST
All lanes:
Western blot - Anti-BMP7 antibody [EPR5897] (ab129156) at 1/1000 dilution
All lanes:
MCF7 (Human breast adenocarcinoma cell line) whole cell lysate at 1/15 dilution
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 49 kDa
Observed band size: 49 kDa
false
- WB
Unknown
Western blot - Anti-BMP7 antibody [EPR5897] (AB129156)
Blocking/Diluting buffer 5% NFDM/TBST
All lanes:
Western blot - Anti-BMP7 antibody [EPR5897] (ab129156) at 1/5000 dilution
Lane 1:
Rat kidney lysate at 20 µg
Lane 2:
Mouse kidney lysate at 20 µg
Secondary
All lanes:
Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG at 1/2000 dilution
Predicted band size: 49 kDa
Observed band size: 49 kDa
false
- WB
Unknown
Western blot - Anti-BMP7 antibody [EPR5897] (AB129156)
The recombinant peptide should give a band of approximately 13.7 kDa.
All lanes:
Western blot - Anti-BMP7 antibody [EPR5897] (ab129156) at 1/1000 dilution
All lanes:
recombinant Human BMP7 (amino acids 316 - 431) at 0.01 µg
Secondary
All lanes:
Goat anti-rabbit HRP at 1/2000 dilution
Predicted band size: 49 kDa
false
- WB
Unknown
Western blot - Anti-BMP7 antibody [EPR5897] (AB129156)
All lanes:
Western blot - Anti-BMP7 antibody [EPR5897] (ab129156) at 1/1000 dilution
Lane 1:
Fetal kidney lysate at 10 µg
Lane 2:
Human prostate lysate at 10 µg
Lane 3:
HT-1376 lysate at 10 µg
Secondary
All lanes:
HRP labelled goat anti-rabbit at 1/2000 dilution
Predicted band size: 49 kDa
false
Related conjugates and formulations (1)
-
Anti-BMP7 antibody [EPR5897] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (12)
Recent publications for all applications. Explore the full list and refine your search
Reproductive sciences (Thousand Oaks, Calif.) 32:2970-2984 PubMed40789984
2025
Applications
Unspecified application
Species
Unspecified reactive species
Heliyon 9:e22487 PubMed38094047
2023
Applications
Unspecified application
Species
Unspecified reactive species
Heliyon 9:e19934 PubMed37809369
2023
Applications
Unspecified application
Species
Unspecified reactive species
Bioengineered 13:13689-13702 PubMed35707851
2022
Applications
Unspecified application
Species
Unspecified reactive species
Journal of nanobiotechnology 19:402 PubMed34863187
2021
Applications
Unspecified application
Species
Unspecified reactive species
Diabetology & metabolic syndrome 13:137 PubMed34801077
2021
Applications
Unspecified application
Species
Unspecified reactive species
Molecular therapy : the journal of the American Society of Gene Therapy 30:763-781 PubMed34678513
2021
Applications
Unspecified application
Species
Unspecified reactive species
Science advances 7: PubMed33627425
2021
Applications
Unspecified application
Species
Unspecified reactive species
eLife 9: PubMed33006314
2020
Applications
Unspecified application
Species
Unspecified reactive species
FASEB journal : official publication of the Federa 33:3212-3224 PubMed30383450
2018
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com